Natco rma is a leading company for the launch of various different generic medicines like Epclusa VELPANAT tablets. As per the recent developments, the company has made an announcement regarding the launch of the first generic form of Epclusa VELPANAT (Velpatasvir 100 mg and Sofosbuvir 400 mg) for the cure of Hepatitis C.
The Epclusa VELPANAT is the generic version of US Company Gilead Sciences new drug is called Epclusa. The generic VELPANAT tablets are helpful for treatment of all Hepatitis C adults that are suffering from genotype 1-6 chronic hepatitis C virus.
Natco recently signed a non-exclusive licensing agreement with Gilead Sciences in order to manufacture and sell VELPANAT tablets, generic chronic hepatitis C drugs in 101 developing nations. This is in the fixed-dose combination for the patients who are suffering from the chronic Hepatitis C.
Prices on VELPANAT tablets almost a hundred times lower than the prices of US medicines, and are accessible to people of all income levels undoubtedly.
Chawla Medicos is a leading supplier of Epclusa in India that provides quality medicines around the world with affordable prices. Our objective is to help people that are suffering from Hepatitis C and other serious life-threatening diseases across the world in procuring Indian medicines which are trusted by doctors. We work with doctors in many hospitals, medical practitioners, and institutions.
We deliver VELPANAT tablets worldwide. Our clients can at any time get high-quality professional advice.
Side effects of velpatasvir:
• Fatigue• A headache• Insomnia• Anemia• Nausea
How did this work?Since velpatasvir is an antiviral medicine, it aids by lowering the amount of hepatitis C in the body and removing the virus completely from the blood vessels after some time.
Signup today to claim your Discount. Get Started before it's too late!
